Global Markets Direct’s “Top 10 Medical Equipment Trends in 2009” report an essential source of information and analysis that will help answer questions like: which companies are poised for high growth in the coming few years?, which are the growth sectors?, how are competitors responding to changing market dynamics?, what products are in pipeline and how would they impact sector growth?, which medical equipment sectors would retain investor confidence?, and what are the regulatory trends in leading economies and emerging economies? These are among the many questions that will be answered with insightful analysis in this report. The report analyses the ten major trends expected to influence the future of global medical equipment industry.
A strong understanding of the key trends to impact the medical equipment industry will prove to be a decisive factor in strategic planning and decision making for all involved in the value chain - investors, manufacturers, distributors, regulators, payer/providers and analysts tracking this industry.
Scope
The report covers information and analysis on medical equipment markets in North America, Europe, Asia Pacific, South Central America, Middle East and Africa.
The report provides market size data and information on 10 medical equipment markets namely Cardiovascular devices, Orthopedic devices, Diagnostic Imaging, Anesthesia and respiratory devices, Drug delivery devices, ENT devices, Healthcare IT, Hospital supplies, In-vitro diagnostics and Diabetes care devices.
Annualized market revenues data from 2000 to 2007, forecast forward for 5 years to 2012.
Analysis and review of the key events and milestones that will impact the future of medical equipment market globally. Each trend independently researched to provide qualitative analysis of • what the implications on sectors are, and how are companies responding to these trends.
Insightful review of key industry drivers, restraints and challenges which are likely to impact the global medical equipment industry in the long run.
In-depth analysis of the medical equipment M&A landscape with a strong emphasis on the market players, likely to remain active in the near future.
Key topics covered include the emergence of Direct to Consumer (DTC) marketing, increasing use of home and self care medical devices, the likely impact of the ongoing credit crunch and the expected landscape post the US presidential elections.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Markets Direct’s team of industry experts.
Reasons to buy
Develop business strategies by understanding the trends shaping and driving the global medical equipment industry.
Organize your sales and marketing efforts by identifying the prevalent and expected competitive landscape in different medical equipment markets.
Design and develop more effective product development, marketing and sales strategies.
Identify key players who are best positioned to take advantage of the emerging market opportunities.
Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
What’s the next being thing in the medical equipment technology landscape? – Identify, understand and capitalize.
Do better by understanding the regulatory scenario in the leading economies. evaluate approval process and reimbursement trends to make your expansion plans more efficient, effective and timely.
1 Table of Contents 2
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is this Report About?
2.2 Global Markets Direct Report Coverage
2.3 Definitions
2.3.1 Anesthesia and Respiratory Devices
2.3.2 Cardiovascular Devices
2.3.3 Dental Devices
2.3.4 Diabetes Care Devices
2.3.5 Diagnostic Imaging
2.3.6 Drug Delivery Devices
2.3.7 Endoscopy Devices
2.3.8 ENT Devices
2.3.9 Healthcare IT
2.3.10 Hospital Supplies
2.3.11 In Vitro Diagnostics
2.3.12 Nephrology and Urology Devices
2.3.13 Neurology Devices
2.3.14 Ophthalmic Devices
2.3.15 Orthopedic Devices
2.3.16 Patient Monitoring
2.3.17 Surgical Equipment
2.3.18 Wound Care Management
3 Top 10 Medical Equipment Trends in 2009
3.1 Executive Summary
4 Direct-to-consumer Advertising: Increased adoption to heat the market space
4.1 Overview
4.2 The FDA and the US Senate Special Committee on Aging
4.3 Reasons Companies are adopting DTC Advertising as a marketing strategy
4.4 DTC Advertising in the Cardiovascular Devices Market
4.5 DTC Advertising in the Orthopaedic Devices Market
4.6 DTC Advertising in Optometry
4.7 Future Outlook
5 Emerging Medical Device Technology Economies
5.1 Overview
5.2 Medical Device Technology in China
5.2.1 Regulatory Landscape
5.2.2 Operational Issues
5.3 Medical Device Technology in Russian Federation
5.3.1 Regulatory Landscape
5.3.2 Operational Issues
5.4 Medical Device Technology in Brazil
5.4.1 Regulatory Landscape
5.4.2 Operational Issues
5.5 Medical Device Technology in India
5.5.1 Regulatory Landscape
5.5.2 Operational Issues
5.6 Medical Device Technology in Taiwan
5.6.1 Regulatory Landscape
5.6.2 Operational Issues
5.7 Medical Device Technology in Republic of Korea
5.7.1 Regulatory Landscape
5.7.2 Operational Issues
5.8 Medical Tourism
5.8.1 Medical Tourism in India
6 Healthcare IT: Redefining the healthcare delivery and management
6.1 Overview
6.2 Impact of Healthcare IT
6.3 Healthcare Interoperability
6.4 Telehealth
6.4.1 PACS in Telehealth
6.4.2 Hospital Information Systems in Telehealth
6.5 Future Outlook
7 Drug eluting stents: Renewed flow in the US market
7.1 Overview
7.2 Is Drug Eluting Stent Safe?
7.2.1 HORIZONS AMI Trial
7.2.2 Medtronic’s Third-Generation Endeavor Resolute
7.2.3 Abbott Laboratories SPIRIT I, II, III
7.3 Companies to Benefit
7.3.1 Boston Scientific
7.3.2 Abbott Laboratories
7.3.3 Medtronic
7.4 Future Outlook
8 The US hip resurfacing market: Over-hyped or else?
8.1 Overview
8.2 Reasons for Smith & Nephew’s Dominance
8.3 The US Hip Resurfacing Market Restraints
8.4 Conclusions
9 The Global Home Healthcare Equipment Market: Poised for robust return
9.1 Overview
9.2 Diabetes Care Devices
9.3 ENT Devices – Hearing Aids
9.4 Respiratory Devices
9.4.1 Continuous Positive Airway Pressure Devices (CPAP) and Nebulizers
9.5 Drug Delivery Devices
9.5.1 Inhalation Systems
9.5.2 Needle Free Injections
9.5.3 Infusion Pumps
9.6 Future Outlook
9.6.1 Wireless Technology
10 Companies to watch out for in 2009
10.1 Overview
10.2 Abbott Laboratories
10.2.1 Abbott Vascular
10.2.2 Abbott Diagnostics
10.2.3 Abbott Diabetes Care
10.3 Medtronic Corporation
10.3.1 Medtronic - Spinal Market
10.3.2 Medtronic - Cardiovascular (includes Cardiac Rhythm Management)
10.3.3 Medtronic – Biologics and Neurology Devices
10.3.4 Medtronic Diabetes Care – Third generation Guardian continuous glucose monitoring system
10.4 Hologic Corporation
10.4.1 Breast Tomosynthesis
10.5 Small Bone Innovations
10.6 Getinge AB
10.7 Integra
10.8 Edward Lifesciences Corporation
10.9 Core Essence Orthopedics Inc (Core)
10.10 Alcon - AcrySof ReSTOR Toric IOL
10.11 Volcano Corporation – IVUS Guided Balloon Catheter
10.12 AcuFocus Inc – AcuFocus ACI 7000
11 Wall Street financial crisis: What’s in store for the medical equipment industry?
11.1 A Backgrounder
11.2 The Medical Equipment Industry Perspective
11.3 Global Medical Equipment Deal Landscape
11.4 Impact Analysis
11.4.1 Montagu Private Equity terminates the sale of BSN Medical
11.4.2 Boston Scientific Corporation’s founders unload stock
11.4.3 Roche to acquire Genentech
11.5 Future Outlook
12 Barack Obama as the US President: Medical Equipment Industry perspective
12.1 Introduction
12.2 Issues in front of the US Healthcare System
12.3 Impact of Rising Healthcare costs
12.4 Barack Obama’s Healthcare Reforms Plan
12.4.1 Implications of Barack Obama’s Plan
12.4.2 Drawbacks of Barack Obama’s Plan
12.5 Medical Equipment Industry future in Barack Obama’s reign
13 Medical Equipment M&A Landscape for 2009
13.1 Overview
13.2 Acquisitions
13.2.1 Medtronic to acquire CryoCath Technologies: A move to strengthen stake in the atrial fibrillation market
13.2.2 Getinge to acquire Datascope: Another Cardiovascular leader in making
13.2.3 Zimmer Holdings to acquire Abbott Spine: A move to fortify the spine portfolio
13.2.4 GE Healthcare acquires Vital signs: A move to consolidate the anesthesia and respiratory product portfolio
13.3 Future Outlook
14 Appendix
14.1 Methodology
14.2 Coverage
14.3 Secondary Research
14.4 Primary Research
14.5 Models
14.6 Forecasts
14.7 Expert Panels
14.8 Contact Us
14.9 Disclaimer 1
1.1 List of Tables
Table 1: Major DTC Advertising Campaigns
Table 2: Orthopedic Devices , US, Overall Revenue ($ mn), 2000 – 2012
Table 3: Medical Equipment, China, Overall Revenue ($ mn), 2000 – 2012
Table 4: Medical Equipment, Russian Federation, Overall Revenue ($ mn), 2000-2012
Table 5: Medical Equipment, Brazil, Overall Revenue ($ mn), 2000 – 2012
Table 6: Medical Equipment, India, Overall Revenue ($ mn), 2000 – 2012
Table 7: Medical Equipment, Taiwan, Overall Revenue ($ mn), 2000-2012
Table 8: Medical Equipment, Republic of Korea, Overall Revenue ($ mn), 2000 – 2012
Table 9: Procedure costs , US, UK, India, Thailand, Singapore, ($), 2008
Table 10: Medical Tourism, India, Overall Revenue ($ mn), 2000 – 2012
Table 11: Healthcare IT, Global, Overall Revenue ($ mn), 2000 – 2012
Table 12: Healthcare IT, Revenue Breakup by Geography ($mn), 2007
Table 13: PACS, Global, Overall Revenue ($ mn), 2000 – 2012
Table 14: Hospital Information Systems, Global, Overall Revenue ($ mn), 2000 – 2012
Table 15: Healthcare IT, India, Overall Revenue ($ mn), 2000 – 2012
Table 16: Coronary Stent, US, Overall Revenue ($ mn), 2000 – 2007
Table 17: Drug Eluting Stent, US, Overall Revenue ($ mn), 2007 – 2012
Table 18: Hip Resurfacing, US, Overall Revenue ($ mn), 2006 – 2012
Table 19: Home Healthcare Equipment, Global, Overall Revenue ($ mn), 2007 – 2012
Table 20: Diabetes care devices, Global, Overall Revenue ($ mn), 2000 – 2012
Table 21: Glucose Monitoring and Insulin Delivery devices, Global, Overall Revenue ($ mn), 2000-2012
Table 22: Digital Signal Processing Hearing Aids, Global, Overall Revenue ($ mn), 2000 - 2012
Table 23: CPAP and Nebulizers, Global, Overall Revenue ($ mn), 2000 – 2012
Table 24: Drug Delivery Devices, Global, Overall Revenue ($ mn), 2000 – 2012
Table 25: Dry Powdered Inhalers, Global, Overall Revenue ($ mn), 2000 – 2012
Table 26: Needle Free Injections, Global, Overall Revenue ($ mn), 2007-2012
Table 27: Infusion Pumps, Global, Overall Revenue ($ mn), 2000 – 2012
Table 28: In Vitro Diagnostics, Global, Overall Revenue ($ mn), 2007-2012
Table 29: Spinal Surgery, Global, Overall Revenue ($ mn), 2007-2012
Table 30: Spinal non-fusion, US, Overall Revenue ($ mn), 2007 – 2012
Table 31: Aortic Stent Graft, US, Overall Revenue ($ mn), 2000-2012
Table 32: Glucose Monitoring, US, Overall Revenue ($ mn), 2000 – 2012
Table 33: Full Field Digital Mammography, Global, Overall Revenue ($ mn), 2000 – 2012
Table 34: Hospital Supplies, Global, Overall Revenue ($ mn), 2000 – 2012
Table 35: Arthroscopy, US, Overall Revenue ($ mn), 2000 – 2012
Table 36: Intra Ocular Lens , US, Overall Revenue ($ mn), 2000 – 2012
Table 37: Soft Contact Lens, US, Overall Revenue ($ mn), 2000 – 2012
Table 38: The US National Health Expenditures, 2006 ($ bn)
Table 39: Number of persons without health insurance, US, 1997 – March, 2008
Table 40: Medical Equipment Financial Deals, January 1, 2008 – November 5. 2008
Table 41: Medical Equipment Financial Deals, by Market, January 1, 2008 – November 5. 2008
Table 42: Medical Equipment Acquisitions, by Market, January 1, 2008 – November 5. 2008
1.2 List of Figures
Figure 1: Cardiovascular, US, Diseases %, 2007
Figure 2: Orthopedic Devices , US, Overall Revenue ($ mn), 2000 – 2012
Figure 3: Medical Equipment, China, Overall Revenue ($ mn), 2000 – 2012
Figure 4: Medical Equipment, Russian Federation, Overall Revenue ($ mn), 2000-2012
Figure 5: Medical Equipment, Brazil, Overall Revenue ($ mn), 2000 – 2012
Figure 6: Medical Equipment, India, Overall Revenue ($ mn), 2000 – 2012
Figure 7: Medical Equipment, Taiwan, Overall Revenue ($ mn), 2000 – 2012
Figure 8: Medical Equipment, Republic of Korea, Overall Revenue ($ mn), 2000 – 2012
Figure 9: Medical Tourism, India, Overall Revenue ($ mn), 2002 – 2012
Figure 10: Healthcare IT, Global, Overall Revenue ($ mn), 2000 – 2012
Figure 11: Healthcare IT, Revenue Breakup by Geography (%), 2007
Figure 12: PACS, Global, Overall Revenue ($ mn), 2000 – 2012
Figure 13: PACS, Global, Company Share (%), 2007
Figure 14: Hospital Information Systems, Global, Overall Revenue ($ mn), 2000 – 2012
Figure 15: Hospital Information Systems, Global, Company Share (%), 2007
Figure 16: Healthcare IT, India, Overall Revenue ($ mn), 2000 – 2012
Figure 17: Coronary Stent, US, Overall Revenue ($ mn), 2000 – 2007
Figure 18: Drug Eluting Stent, US, Overall Revenue ($ mn), 2007 – 2012
Figure 19: Drug Eluting Stent, US, Company Share (%), 2007
Figure 20: Hip Resurfacing, US, Company Share (%), October 2008
Figure 21: Hip Resurfacing, US, Overall Revenue ($ mn), 2006 – 2012
Figure 22: Home Healthcare Equipment, Global, Overall Revenue ($ mn), 2007-2012
Figure 23: Diabetes care devices, Global, Overall Revenue ($ mn), 2000 – 2012
Figure 24: Glucose Monitoring and Insulin Delivery devices, Global, Overall Revenue ($ mn), 2000-2012
Figure 25: Diabetes Care Devices, Global, Company Share (%), 2007
Figure 26: Digital Signal Processing Hearing Aids, Global, Overall Revenue ($ mn), 2000 - 2012
Figure 27: Digital Signal Processing Hearing Aids, Global, Company Share (%), 2007
Figure 28: Respiratory Devices , Global, Company Share (%), 2007
Figure 29: CPAP and Nebulizers, Global, Overall Revenue ($ mn), 2000 – 2012
Figure 30: Drug Delivery Devices, Global, Overall Revenue ($ mn), 2000 – 2012
Figure 31: Dry Powdered Inhalers, Global, Overall Revenue ($ mn), 2000 – 2012
Figure 32: Needle Free Injections, Global, Overall Revenue ($ mn), 2007-2012
Figure 33: Infusion Pumps, Global, Overall Revenue ($ mn), 2000 – 2012
Figure 34: In Vitro Diagnostics, Global, Overall Revenue ($ mn), 2007 – 2012
Figure 35: Spinal Surgery, Global, Overall Revenue ($ mn), 2007 – 2012
Figure 36: Spinal non-fusion, US, Overall Revenue ($ mn), 2007 – 2012
Figure 37: Aortic Stent Graft, US, Overall Revenue ($ mn), 2000-2012
Figure 38: Glucose Monitoring, US, Overall Revenue ($ mn), 2000 – 2012
Figure 39: Mammography equipment, Global, Companies, %, 2007 88
Figure 40: Full Field Digital Mammography, Global, Overall Revenue ($ mn), 2000 – 2012
Figure 41: Hospital Supplies, Global, Overall Revenue ($ mn), 2000 – 2012
Figure 42: Cardiovascular Prosthetic Devices, Global, Companies, %, 2007
Figure 43: Arthroscopy, US, Overall Revenue ($ mn), 2000 – 2012
Figure 44: Intra Ocular Lens , US, Overall Revenue ($ mn), 2000 – 2012
Figure 45: Soft Contact Lens, US, Overall Revenue ($ mn), 2000 – 2012
Figure 46: Share price trends of leading medical equipment pure-plays, 2008
Figure 47: Share price trends of leading medical equipment pure-plays, January, 2005 – October, 2008
Figure 48: Global Medical Equipment Deal Landscape, 2008
Figure 49: Macro-environment Risk Susceptibility, Leading Medical Equipment Companies
Figure 50: Boston Scientific Corporation, Share Price ($), Adj Close*, January 02, 2008 – October 31, 2008
Figure 51: Genentech, Share Price ($), Adj Close*, July 18, 2008 – October 31, 2008
Figure 52: The US National Health Expenditures, Providers, %, 2006
Figure 53: Medical Equipment Financial Deals, January 1, 2008 – November 5. 2008
Figure 54: Medical Equipment Financial Deals, by Market, January 1, 2008 – November 5. 2008
Figure 55: Medical Equipment Acquisitions, by Market, January 1, 2008 – November 5. 2008
Figure 56: Electrophysiology Market, Global, Company Share, %, 2007
Figure 57: Electrophysiology Market, Global, Overall Revenue ($mn), 2000-2012
Figure 58: Cardiovascular Surgery & Cardiac Assist Devices Market, Global, Overall Revenue ($mn), 2007-2012
Figure 59: Global Markets Direct Methodology
For more pls visit
http://www.bharatbook.com/Market-Research-Reports/Top-10-Medical-Equipment-Trends-in-2009.html